Table 3.
Pathological characteristics of the patients in our study.
Characteristics | LR (n = 153) | HR (n = 49) | P-value |
---|---|---|---|
Pathological staging, n (%) | 0.0004 | ||
pI | 53 (34.6%) | 15 (30.6%) | |
pII | 74 (48.4%) | 16 (32.7%) | |
pIII | 20 (13.1%) | 14 (28.6%) | |
pIV | 6 (3.9%) | 4 (8.1%) | |
Histological grade, n (%) | 0.0232 | ||
G1 | 71 (46.4%) | 13 (26.5%) | |
G2 G3 and non-endometrial carcinoma |
48 (31.4%) | 17 (34.7%) | |
34 (22.2%) | 19 (38.8%) |
LR, low-risk group; HR, high-risk group. Bold type indicates statistically significant difference.